Study the involvement of the signaling pathways responsible for the development of PAH, such as BMPR-2 (Bone morphogenic protein receptor type 2) and ALK-1 (Activin A receptor type II-like kinase-1), in response to nutraceutics. The gene discussed is ACVRL1; the disease is pulmonary arterial hypertension.